August 19, 2019
Prominent hospital ratings systems are highly influential, but they also can generate contradictory results that do not always align with clinicians' own assessments, a group of authors write in NEJM Catalyst, highlighting the shortcomings of several major hospital ratings systems.
Pharmacy benefit managers in 2016 passed on nearly all of the rebates they negotiated with pharmaceutical companies for Medicare Part D drugs to insurers sponsoring Part D plans, resulting in lower premiums for such plans, according to a Government Accountability Office report released Wednesday.
August 16, 2019
CMS on Thursday announced it will require state and federal exchange websites to display quality star ratings for Affordable Care Act exchange plans, starting with the 2020 open enrollment period.
FDA on Thursday unveiled 13 proposed graphic warning labels about the health risks of smoking that, if finalized, would appear on the packaging of all cigarettes sold in the United States. See the proposed warning labels—and what experts are saying about their effectiveness.
Thirteen states and two California counties this week filed lawsuits against the Trump administration's final rule that will allow federal officials to consider whether immigrants are receiving or are likely to receive Medicaid or other public benefits when reviewing their residency applications.
Planned Parenthood on Wednesday announced it will formally withdraw from the Title X federal family planning program by Aug. 19 unless a federal court blocks a Trump administration rule that bars clinics that receive Title X funding from abortions providing or referring patients to non-emergency abortion care.
American Health Line rounds up the latest health care news in the states.
A federal appeals court on Tuesday reversed a lower court's ruling and reinstated a 2017 rule that changed how CMS calculates Medicaid disproportionate-share hospital payments to ensure providers are not doubly compensated for care costs covered by third-party insurers.
August 15, 2019
FDA on Wednesday approved a new antibiotic, called pretomanid, to treat highly drug-resistant strains of tuberculosis, which kills about 500,000 of the 1.6 million individuals who die annually from the infectious disease.
FDA on Monday warned patients not to drink certain solutions being marketed as cures for autism, cancer, HIV/AIDs, and other diseases and conditions, saying the solutions become a "dangerous bleach" when mixed with citric acids.
Advisory Board. All rights reserved.